Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-107.62%EBITDA Margin
VS
Market
Sector
Industry
History
$ 7.08Close
$ 2.22 - $ 7.34 52-Week Range
Ticker Information
Ticker
AQSTCompany Name
AQUESTIVE THERAPEUTICS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQAQUESTIVE THERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
AQST - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -47.49M | -107.62% | $ 44.13M |
| 3/31/2025 | $ -36.71M | -67.69% | $ 54.23M |
| 12/31/2024 | $ -26.62M | -46.24% | $ 57.56M |
| 9/30/2024 | $ -18.23M | -30.94% | $ 58.9M |
| 6/30/2024 | $ -11.67M | -20% | $ 58.36M |
| 3/31/2024 | $ -17.12M | -33.24% | $ 51.5M |
| 12/31/2023 | $ 1.18M | 2.34% | $ 50.58M |
| 9/30/2023 | $ -4.76M | -9.91% | $ 48.06M |
| 6/30/2023 | $ -12.41M | -26.69% | $ 46.52M |
| 3/31/2023 | $ -20.69M | -44.44% | $ 46.54M |
Key Performance Insights, Last 5 Years
- AQUESTIVE THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA % stands at -61.49%.
- Over the past 5 years, AQUESTIVE THERAPEUTICS INC's average EBITDA % has been -62.62%.
- The median EBITDA % for AQUESTIVE THERAPEUTICS INC during this period was -69.39%
- AQUESTIVE THERAPEUTICS INC reached its highest EBITDA % over the past 5 years at 2.34%.
- The lowest EBITDA % recorded by AQUESTIVE THERAPEUTICS INC in the same timeframe -111.62%
AQUESTIVE THERAPEUTICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for AQUESTIVE THERAPEUTICS INC is calculated as follows: EBITDA [ $ -33.89M ] / Revenues [ $ 55.12M ]
(=) EBITDA % [ -61.49% ] AQST - EBITDA Margin, Last 5 years
-111.62%
Minimum
Sep 30, 2022
2.34%
Maximum
Dec 31, 2023
-62.62%
Average
-69.39%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |